Using tumor lab markers during adrenal cancer care
Treatments studied
Part of Cancer clinical trials.
This trial studies how to use lab tests (“molecular markers”) in routine clinical care to help manage people with adrenal tumors that could be cancerous. If you are having surgery soon (or recently), your tissue may be tested to see if these markers improve decision-making for your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have an adrenal tumor and be planning surgery soon, or had surgery within the last 2 months
- Your tumor should match one of these: possible adrenal cancer, or pheochromocytoma, or paraganglioma
- Be covered by France’s Social Security healthcare system (have a social security regime)
- Agree to join by signing informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how adrenal hormone tumor diseases should be diagnosed, treated, and followed over time. It may help people get more precise care and better prediction of outcomes, but it has specific health and medication requirements.
This study looks at CT scans of people with adrenal tumors to understand how the tumor might affect your metabolism. It may help doctors learn more about the condition and improve care.
This study collects and analyzes molecular (cell/DNA-level) information from endocrine tumors or pre-cancer conditions. It may help doctors better understand these tumors and improve diagnosis and treatment planning when you need surgery or a biopsy.
This study is collecting information from people with certain adrenal gland tumors (pheochromocytoma, paraganglioma, or adrenocortical tumor). It aims to learn more about these conditions, which may help improve future care. Both living and deceased patients can be included.
This trial tests whether adding a type of immunotherapy (pembrolizumab) to targeted radiation can help people with adrenal cancer that has spread to the liver. It aims to shrink tumors and slow the cancer's growth.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.